Peptide-based therapeutics are increasingly being seen as the future for many drug development programs, and these compounds can be found in many clinical therapeutic areas such as cancer vaccines, personalized medicines, and treatments for metabolic and cardiovascular diseases. But how do researchers in academia and industry chose a target peptide for a particular therapy? What challenges do they face when chemically synthesizing peptides as part of process development, or manufacture? Join this panel discussion where selected experts in the field will discuss these topics and answer your questions!

Date: 4 March 2021 (Thursday)  

Time: 12:00 AM - 1:00 AM (HK time)

Registration Link: https://register.gotowebinar.com/register/1954849622469095952

LEARNING OBJECTIVES:

•Learn from experts in the field of peptide drug development, discovery and chemical synthesis.

•Understand what factors influence target selection.

•Learn how to overcome solid phase peptide synthesis challenges such as increasing purity and yield of the target product, and reducing impurities and side-products.

•Learn how to optimize your peptide synthesis with a focus on scale-up and manufacture.

How can we improve the purification process? This webinar will look at current techniques in purification, including Peptide Easy-Clean (PEC) Technology.